[Evaluation of percutaneous microwave hepatic tumor coagulation therapy (PMTC) under general anesthesia from viewpoint of quality of life (QOL)].
We evaluated clinical benefits (QOL and local control rate) of percutaneous microwave coagulation therapy conducted with general anesthesia. Five cases with hepatic tumor (3 cases with hepatocellular carcinoma, 2 cases with metastatic hepatic tumor) were enrolled. The day following treatment all patients were virtually free of complaints with performance status ranging 0 to 1, and they were discharged from the hospital within 1 week. Four of five cases could be controlled solely with this treatment: one case showed local relapse, the tumor size of which exceeded 3 cm. PMTC may be one of the most beneficial local treatments for malignant hepatic tumor, since it shortens hospital stay with a good QOL status, and is applicable to metastatic tumor.
Niinobu
T
T
Dept. of Surgery, Toyonaka Municipal Hospital.
Shibata
T
T
Takami
M
M
Tsujinaka
T
T
Takada
T
T
Kitada
M
M
Tsukahara
Y
Y
Murotani
M
M
Iihara
K
K
Tsukamoto
F
F
Ogawa
M
M
Kimura
M
M
D000368:Aged; D000768:Anesthesia, General; D006528:Carcinoma, Hepatocellular / Q000601:surgery*; D004564:Electrocoagulation; D005260:Female; D006801:Humans; D008113:Liver Neoplasms / Q000601:surgery*; D008297:Male; D008872:Microwaves / Q000627:therapeutic use*; D008875:Middle Aged; D011788:Quality of Life